US Stock MarketDetailed Quotes

XLO Xilio Therapeutics

Watchlist
  • 1.090
  • +0.080+7.92%
Close Apr 26 16:00 ET
  • 1.060
  • -0.030-2.75%
Post 17:39 ET
40.23MMarket Cap-392P/E (TTM)

Xilio Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Xilio Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.64

+21.95%
Analyst Rating

No Data

Xilio Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 10.000M--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 10.000M--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Xilio Therapeutics Earnings Reports

  • Xilio Therapeutics | 10-K: Annual report

    Apr 1 16:27 ET

  • Xilio Therapeutics | 10-Q: Quarterly report

    Nov 9, 2023 16:17 ET

  • Xilio Therapeutics | 10-Q/A: Quarterly report (Amendment)

    Nov 9, 2023 16:10 ET

  • Xilio Therapeutics | 10-Q/A: Quarterly report (Amendment)

    Nov 9, 2023 16:08 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg